Avidity Biosciences (NASDAQ:RNA) has outperformed the market over the past 5 years by 6.63% on an annualized basis producing an average annual return of 19.41%. Currently, Avidity Biosciences has a market capitalization of $10.62 billion.
Buying $100 In RNA: If an investor had bought $100 of RNA stock 5 years ago, it would be worth $229.57 today based on a price of $70.47 for RNA at the time of writing.
Avidity Biosciences's Performance Over Last 5 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
